Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
Torrent Pharmaceuticals announced Q4FY23 results: Q4FY23: Revenue at Rs 2,491 crore up by 17% Gross margins: 72%; Op. EBITDA margins: 29.2% Op. EBITDA at Rs 727 crore was up by 30% Profit after tax at Rs 287 crore FY23: Revenue at Rs 9,620 crore up by 13% Gross margins: 71%; Op. EBITDA margins: 29% Op. EBITDA at Rs 2,842 crore was up by 17% Profit after tax at Rs 1,245 crore Result PDF